OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles.

So here is a new title

This one has got the charts at the top again & has a link to the old one.
http://www.moneyam.com/InvestorsRoom/posts.php?tid=5021

Queen 1

Sherlock you most definetly are not. More like
Miss Marple.

I can assure you I most definetly am not Dil or
anyone else. The only name/number I have used on
the moneyam website is 1704. Please check with
whoever runs this the website if you don't believe me.

I only mentioned your comments on the Yoo thread as
tonue-in-cheek joke. I agreed with the points that you
raised and how you stuck to your guns in making your point.

Is "1704" a special date or other meaning?

Barry- Thanks for your post. Now to clear up
the meaning. (I think Prince had the right idea
calling himself 'Symbol')

1704 does have a special meaning to me the birthday
of my first wife is the 17th April. Hence 1704 clever innit.

Come to think of it not a word to my second wife her
birthday is the 12th April.

1704 - glad that you agreed with the comments on the YOO thread. But I still find it strange that the attacking poster from there (Dil) and yourself (1704) seem to be one and the same (dil1704) in the Shares mag Champion Investor competition. Or perhaps that individual has a partner called Dil who shares the same birthday as your first wife. Now what a coincidence that would be!

Queen 1.

For the second time Sherlock you are not. More
like Miss Marple. Good detectives make sure they
cover all clues or evidence before making the type
of suggestions you have done. If you would like to
continue believing that I am Dil or anyone else
for that matter feel free to do so. Whoever runs
the moneyam website would confirm that your theories
are way off the market.

Mind you its good to know that despite the heatwave
that we have experienced over the weekend I can get
female strangers thinking about my true identity.
This has done my ego no harm at all.

Now who's making assumptions 1704?

Queen 1

Are you trying to tell me my assumptions are wrong?
Surely not. Your in love with me just admit it and
try to move on.

All the best my Queen xxxxxxxxxx

I have taken a look at the YOO thread and only hope that this one does not go the same way. Please can we just share info about OXB on this thread as I am really not interested in juvenile chatroom posts, can you two just call it a day there - the next one to make a comment if it's not about OXB loses ok. Thank you.

Robstuff- Ok point taken. Keep your hair on.

Too late, I'm bald :)

Whoops, I lost! A Momentary lapse of concentration. Anyone know when the BIO Convention is? Their lentivector technology i think has excellent licencing potential, a good presentation could lead to some more deals. The bid rumours seem to hve faded which is good news and should mean the sp holding at these levels before the next positive news pushes them above 40p. I still believ 50p by the yr end is easily achievable.

About to announce something big I shouldn't wonder.

Well it's good to see momentum restored as they had been very slowly drifting south again.

MMs know an announcement is imminent, something's been leaked, expect news tomorrow and a big mark up.

May see 40p breached tomorrow

definitely something going on, sp staying up with recent loads of sells - mms accumulating.

Oxford Biomedica PLC
30 June 2005


Oxford BioMedica plc (the 'Company')

Notification of Major Interests in Shares

The Company has received notification from Calyon Corporate and Investment Bank
that on 29 June 2005 Credit Agricole Cheuvreux International Ltd had an interest
in 36,917,000 Oxford BioMedica plc 1p ordinary shares. This represents 9.82% of
the presently issued share capital of the Company, which stands at 375,841,175
shares.

good start for the week

This will be the reason why:

Oxford Biomedica gets 2 new lentivirus patents in China
AFX


LONDON (AFX) - Gene therapy group Oxford Biomedica PLC said it was granted two patents by the Patent Office of the Peoples' Republic of China that have broad claims covering vectors derived from lentiviruses.

These are the first patents covering the commercial use of the company's LentiVector technology in China, it said, adding that China is the only

country in the world with an approved gene therapy product.

The LentiVector technology forms the delivery system for the Oxford Biomedica's neurotherapy pipeline, including products for Parkinson's disease, age-related macular degeneration, motor neuron disease, spinal muscular atrophy and nerve repair.

Patents in China might be more valuable then elswhere with the large growth rate in China.

It will be interesting to see what plans OXB has for deals in China.